The effect of oxidation on the enzyme-catalyzed hydrolytic biodegradation of poly(urethane)s.
Although the biodegradation of polyurethanes (PU) by oxidative and hydrolytic agents has been studied extensively, few investigations have reported on the combination of their effects. Since neutrophils (PMN) arrive at an implanted device first and release HOCl, followed by monocyte-derived macrophages (MDM) which have potent esterase activities and oxidants of their own, the combined effect of oxidative and hydrolytic degradation on radiolabeled polycarbonate-polyurethanes (PCNU)s was investigated and compared to that of a polyester-PU (PESU) and a polyether-PU (PEU). The PCNUs were synthesized with PCN (MW = 1,000), and butanediol (14C-BD) and one of two diisocyanates, hexane-1,6-diisocyanate (14C-HDI) or methylene bis-p-phenyl diisocyanate (MDI). The PESU and PEU were synthesized using toluene-diisocyanate (14C-TDI), with polycaprolactone and polytetramethylene oxide as soft segments respectively, and ethylene diamine as the chain extender. The effect of pre-treatment with 0.1 mM HOC1 for 1 week on the HDI-based PCNUs and both TDI-based PUs resulted in a significant inhibition of radiolabel release (RR) elicited by cholesterol esterase (CE), when compared to buffer alone, whereas the MDI-based PCNU showed a small but significant increase. When PMN were activated on the HDI-based PCNU surface with phorbol myristate acetate (PMA), HOCl was released for 3 h, and was almost completely abolished by sodium azide (AZ). Simultaneously, the PMN-elicited RR, shown previously to be due to the esterolytic cleavage by serine proteases, was inhibited approximately 75% by PMA-activation of the cells, but significantly increased relative to the latter when AZ was added. Both in vitro oxidation by HOCl and the release of HOCI by PMN were associated with the inhibition of RR and suggest perturbations between oxidative and hydrolytic mechanisms of biodegradation.
Labow
Rosalind S
RS
University of Ottawa Heart Institute, ON, Canada. rlabow@ottawaheart.ca
Tang
Yiwen
Y
McCloskey
Christopher B
CB
Santerre
J Paul
JP
D001672:Biocompatible Materials / Q000378:metabolism*; D001711:Biotransformation; D006801:Humans; D006997:Hypochlorous Acid / Q000737:chemistry; D008264:Macrophages / Q000201:enzymology / Q000378:metabolism*; D009504:Neutrophils / Q000378:metabolism*; D010084:Oxidation-Reduction; D011076:Polycarboxylate Cement / Q000378:metabolism; D011140:Polyurethanes / Q000378:metabolism*; D019736:Prostheses and Implants; D019810:Sodium Azide / Q000378:metabolism; D002787:Sterol Esterase / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate / Q000378:metabolism
D001672:Biocompatible Materials; D011076:Polycarboxylate Cement; D011140:Polyurethanes; C005506:polycarbonate; D006997:Hypochlorous Acid; D019810:Sodium Azide; D002787:Sterol Esterase; D013755:Tetradecanoylphorbol Acetate